IDEAS home Printed from https://ideas.repec.org/p/osf/socarx/ky4z7.html
   My bibliography  Save this paper

Poder, Disputas y Geopolítica en el Sector Farmacéutico

Author

Listed:
  • Stacciarini, João Henrique Santana

    (Federal University of Goiás)

Abstract

El sector farmacéutico alcanzó ingresos globales de 1,6 billones de dólares en 2023, consolidando su vasto poder económico y su influencia estratégica en la economía y la política contemporáneas. Este artículo, basado en una exhaustiva recopilación, sistematización y análisis de datos, examina las dinámicas de dicho poder e influencia. Se analizan el valor económico y político de las empresas del sector, las disputas entre corporaciones y naciones involucradas, el papel geopolítico desempeñado durante la pandemia de covid-19, así como la capacidad del sector para moldear políticas internas a través de su intensa interacción y financiación de legisladores y organismos de fiscalización y regulación.

Suggested Citation

  • Stacciarini, João Henrique Santana, 2025. "Poder, Disputas y Geopolítica en el Sector Farmacéutico," SocArXiv ky4z7, Center for Open Science.
    • Handle: RePEc:osf:socarx:ky4z7
    DOI: 10.31219/osf.io/ky4z7
    as

    Download full text from publisher

    File URL: https://osf.io/download/67816dd35c1236b13e2f3808/
    Download Restriction: no
    File URL: https://libkey.io/10.31219/osf.io/ky4z7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. ., 2024. "The meeting landscape, its emergence and expansion," Chapters, in: Why Meetings Matter, chapter 3, pages 26-46, Edward Elgar Publishing.
    2. ., 2023. "Stay happy and healthy," Chapters, in: How to be an Academic Superhero, chapter 34, pages 203-207, Edward Elgar Publishing.
    3. DiMasi, Joseph A. & Grabowski, Henry G. & Hansen, Ronald W., 2016. "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, Elsevier, vol. 47(C), pages 20-33.
    4. ., 2023. "Healthcare and elderly care in Europe: an introduction," Chapters, in: Healthcare and Elderly Care in Europe, chapter 1, pages 1-8, Edward Elgar Publishing.
    5. Sarah A. Felknor & Jessica M. K. Streit & Nicole T. Edwards & John Howard, 2023. "Four Futures for Occupational Safety and Health," IJERPH, MDPI, vol. 20(5), pages 1-22, February.
    6. Dasgupta, Shouro & Robinson, Elizabeth J. Z., 2023. "Climate, weather and child health in Burkina Faso," Australian Journal of Agricultural and Resource Economics, Australian Agricultural and Resource Economics Society, vol. 67(04), August.
    7. David T. S. Hayman & Katie Woolaston, 2023. "Pandemic treaty: incorporate a One Health framework," Nature, Nature, vol. 613(7942), pages 27-27, January.
    8. Fazal, Tanisha M., 2020. "Health Diplomacy in Pandemical Times," International Organization, Cambridge University Press, vol. 74(S1), pages 78-97, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Warren, Emily & Boadu, Paul & Exley, Josephine & Williams, Lorraine & Erens, Bob & Knai, Cécile, 2024. "Knowledge and use of voluntary food and drink guidelines in English nurseries? Results from a nationally representative cross-sectional study," Food Policy, Elsevier, vol. 122(C).
    2. Anna Owczarczyk, 2023. "Wykorzystanie e-recepty jako narzędzia wspierającego świadczenie usług w podmiotach ochrony zdrowia," Nowoczesne Systemy Zarządzania. Modern Management Systems, Military University of Technology, Faculty of Security, Logistics and Management, Institute of Organization and Management, issue 3, pages 13-30.
    3. repec:osf:socarx:z5mf6_v2 is not listed on IDEAS
    4. Dosis, Anastasios & Muthoo, Abhinay, 2019. "Experimentation in Dynamic R&D Competition," CRETA Online Discussion Paper Series 52, Centre for Research in Economic Theory and its Applications CRETA.
    5. Yusuke Oh & Koji Takahashi, 2020. "R&D and Innovation: Evidence from Patent Data," Bank of Japan Working Paper Series 20-E-7, Bank of Japan.
    6. Gamba, Simona & Magazzini, Laura & Pertile, Paolo, 2021. "R&D and market size: Who benefits from orphan drug legislation?," Journal of Health Economics, Elsevier, vol. 80(C).
    7. Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022. "Generic competition and the incentives for early-stage pharmaceutical innovation," Research Policy, Elsevier, vol. 51(10).
    8. Shouro Dasgupta & Elizabeth J. Z. Robinson, 2023. "Climate, weather and child health in Burkina Faso," Australian Journal of Agricultural and Resource Economics, Australian Agricultural and Resource Economics Society, vol. 67(4), pages 576-602, October.
    9. Unsal, Omer & Houston, Reza, 2024. "R&D grants and medical innovation," Journal of Economics and Business, Elsevier, vol. 128(C).
    10. Abe C. Dunn & Lasanthi Fernando & Eli Liebman, 2024. "How Much Are Medical Innovations Worth? A Detailed Analysis Using Cost-Effectiveness Studies," BEA Papers 0132, Bureau of Economic Analysis.
    11. Alfred B. Ordman, 2022. "When Will the FDA Do What Is in People’s Best Interests?," American Journal of Economics and Sociology, Wiley Blackwell, vol. 81(4), pages 721-751, September.
    12. Edouard Debonneuil & Anne Eyraud-Loisel & Frédéric Planchet, 2018. "Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?," Risks, MDPI, vol. 6(3), pages 1-27, July.
    13. Billette de Villemeur, Etienne & Versaevel, Bruno, 2019. "One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry," Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
    14. Fabian Gaessler & Stefan Wagner, 2022. "Patents, Data Exclusivity, and the Development of New Drugs," The Review of Economics and Statistics, MIT Press, vol. 104(3), pages 571-586, May.
    15. Yixiang Ruan & Chenyin Lu & Ning Xu & Yuchen He & Yixin Chen & Jian Zhang & Jun Xuan & Jianzhang Pan & Qun Fang & Hanyu Gao & Xiaodong Shen & Ning Ye & Qiang Zhang & Yiming Mo, 2024. "An automatic end-to-end chemical synthesis development platform powered by large language models," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    16. Gregor Dorfleitner & Felix Rößle, 2018. "The financial performance of the health care industry: a global, regional and industry specific empirical investigation," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(4), pages 585-594, May.
    17. Farasat A. S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2021. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Small Business Economics, Springer, vol. 57(1), pages 603-634, June.
    18. Stig Johan Wiklund, 2019. "A modelling framework for improved design and decision-making in drug development," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-22, August.
    19. Yin, Nina, 2023. "Pharmaceuticals, incremental innovation and market exclusivity," International Journal of Industrial Organization, Elsevier, vol. 87(C).
    20. Rathi, Sawan & Majumdar, Adrija & Chatterjee, Chirantan, 2024. "Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? New evidence from patenting data," Technological Forecasting and Social Change, Elsevier, vol. 198(C).
    21. Heyoung Yang & Hyuck Jai Lee, 2018. "Long-Term Collaboration Network Based on ClinicalTrials.gov Database in the Pharmaceutical Industry," Sustainability, MDPI, vol. 10(2), pages 1-14, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:osf:socarx:ky4z7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: OSF (email available below). General contact details of provider: https://arabixiv.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.